
CRBP
Healthcare · Biotechnology · $69.9M market cap
$3.39-0.02 (-0.6%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -6.8% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | Before the open | -1.45 | -1.81 | -24.8% |
| Aug 6, 2026 | Before the open | -1.30 | -1.81 | -39.2% |
| May 12, 2026 | Before the open | -1.22 | -1.23 | -0.8% |
| Mar 9, 2026 | Time not confirmed | -1.58 | -1.25 | +20.7% |
| Nov 12, 2025 | Before the open | -1.71 | -1.90 | -11.1% |
| Aug 5, 2025 | Before the open | -1.33 | -1.44 | -8.3% |
| May 6, 2025 | Before the open | -1.07 | -1.39 | -29.9% |
| Mar 10, 2025 | Before the open | -1.26 | -0.78 | +38.0% |
| Nov 7, 2024 | Before the open | -0.95 | -1.15 | -21.1% |
| Aug 6, 2024 | Before the open | -1.19 | -0.90 | +24.4% |
| May 7, 2024 | Before the open | -1.09 | -0.83 | +23.9% |
| Mar 12, 2024 | Before the open | -2.36 | -1.81 | +23.3% |
| Nov 7, 2023 | Before the open | -2.06 |
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity.…
| -2.27 |
| -10.2% |
| Aug 8, 2023 | Before the open | -3.10 | -2.05 | +33.9% |
| May 9, 2023 | After the close | -4.09 | -4.24 | -3.7% |
| Mar 7, 2023 | Before the open | -2.10 | -2.61 | -24.3% |
| Nov 8, 2022 | After the close | -1.65 | -2.10 | -27.3% |
| Aug 9, 2022 | After the close | -1.80 | -3.30 | -83.3% |
| May 10, 2022 | Before the open | -2.55 | -2.40 | +5.9% |
| Mar 8, 2022 | Before the open | -3.22 | -2.40 | +25.5% |
| Nov 12, 2021 | Before the open | -3.30 | -0.60 | +81.8% |
| Aug 12, 2021 | Before the open | -3.75 | -4.50 | -20.0% |
| May 13, 2021 | Before the open | -4.80 | -4.20 | +12.5% |
| Mar 15, 2021 | Before the open | -7.56 | -3.00 | +60.3% |
| Nov 9, 2020 | After the close | -12.18 | -12.90 | -5.9% |
| Aug 6, 2020 | Before the open | -11.25 | -15.60 | -38.7% |
| May 11, 2020 | After the close | -12.70 | -12.90 | -1.6% |
| Mar 12, 2020 | Before the open | -10.74 | -12.30 | -14.5% |
| Nov 7, 2019 | After the close | -10.90 | -9.60 | +11.9% |
| Aug 8, 2019 | Before the open | -10.68 | 0.90 | +108.4% |
| May 9, 2019 | Before the open | -4.45 | -12.90 | -189.9% |
| Mar 12, 2019 | Before the open | -7.80 | -9.00 | -15.4% |
| Nov 8, 2018 | Before the open | -6.65 | -7.80 | -17.3% |
| Aug 8, 2018 | Before the open | -6.45 | -6.30 | +2.3% |
| May 10, 2018 | Before the open | -4.10 | -6.30 | -53.7% |
| Mar 12, 2018 | Before the open | -4.62 | -6.30 | -36.4% |